Scientists illustrated that tumor-derived interleukin 35 mediated the accelerated resistance of PDAC to gemcitabine (GEM). They observed that GEM resistance can spread from GEM-resistant PDAC cells to GEM-sensitive cells, and that IL-35 was responsible for the propagation of chemoresistance.
[Oncogene]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News